Show simple item record

dc.contributor.authorGoranitis, I
dc.contributor.authorBarton, P
dc.contributor.authorMiddleton, LJ
dc.contributor.authorDeeks, JJ
dc.contributor.authorDaniels, JP
dc.contributor.authorLatthe, P
dc.contributor.authorCoomarasamy, A
dc.contributor.authorRachaneni, S
dc.contributor.authorMcCooty, S
dc.contributor.authorVerghese, TS
dc.contributor.authorRoberts, TE
dc.date.accessioned2020-12-18T03:48:32Z
dc.date.available2020-12-18T03:48:32Z
dc.date.issued2016-08-11
dc.identifierpii: PONE-D-16-08817
dc.identifier.citationGoranitis, I., Barton, P., Middleton, L. J., Deeks, J. J., Daniels, J. P., Latthe, P., Coomarasamy, A., Rachaneni, S., McCooty, S., Verghese, T. S. & Roberts, T. E. (2016). Testing and Treating Women after Unsuccessful Conservative Treatments for Overactive Bladder or Mixed Urinary Incontinence: A Model-Based Economic Evaluation Based on the BUS Study. PLOS ONE, 11 (8), https://doi.org/10.1371/journal.pone.0160351.
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/11343/255927
dc.description.abstractOBJECTIVE: To compare the cost-effectiveness of bladder ultrasonography, clinical history, and urodynamic testing in guiding treatment decisions in a secondary care setting for women failing first line conservative treatment for overactive bladder or urgency-predominant mixed urinary incontinence. DESIGN: Model-based economic evaluation from a UK National Health Service (NHS) perspective using data from the Bladder Ultrasound Study (BUS) and secondary sources. METHODS: Cost-effectiveness analysis using a decision tree and a 5-year time horizon based on the outcomes of cost per woman successfully treated and cost per Quality-Adjusted Life-Year (QALY). Deterministic and probabilistic sensitivity analyses, and a value of information analysis are also undertaken. RESULTS: Bladder ultrasonography is more costly and less effective test-treat strategy than clinical history and urodynamics. Treatment on the basis of clinical history alone has an incremental cost-effectiveness ratio (ICER) of £491,100 per woman successfully treated and an ICER of £60,200 per QALY compared with the treatment of all women on the basis of urodynamics. Restricting the use of urodynamics to women with a clinical history of mixed urinary incontinence only is the optimal test-treat strategy on cost-effectiveness grounds with ICERs of £19,500 per woman successfully treated and £12,700 per QALY compared with the treatment of all women based upon urodynamics. Conclusions remained robust to sensitivity analyses, but subject to large uncertainties. CONCLUSIONS: Treatment based upon urodynamics can be seen as a cost-effective strategy, and particularly when targeted at women with clinical history of mixed urinary incontinence only. Further research is needed to resolve current decision uncertainty.
dc.languageEnglish
dc.publisherPUBLIC LIBRARY SCIENCE
dc.titleTesting and Treating Women after Unsuccessful Conservative Treatments for Overactive Bladder or Mixed Urinary Incontinence: A Model-Based Economic Evaluation Based on the BUS Study
dc.typeJournal Article
dc.identifier.doi10.1371/journal.pone.0160351
melbourne.affiliation.departmentMelbourne School of Population and Global Health
melbourne.source.titlePLoS One
melbourne.source.volume11
melbourne.source.issue8
dc.rights.licenseCC BY
melbourne.elementsid1309701
melbourne.contributor.authorGoranitis, Ilias
dc.identifier.eissn1932-6203
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record